INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProMethodologyMatch reviewLaunch readiness
Public company

CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE

CIK 0001801170

EDGAR filingsOpen in network
Disclosed transactions56
Buys / sells0 / 23
Max Insider Score43
Connections15with evidence

CLOV · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
13
RL
Reynoso Jamie L.CEO, Medicare Advantage
CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
Open-market sale · 10b5-1 plan
SELL$18K
4,066 sh
Oct 19, 2026Oct 20, 2026
traded Oct 19, 2026
+1dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 6324 · Hospital & Medical Service Plans · Nov 4, 2026
  • In industryevidence
    Banking, securities & insuranceSEC SIC 6324 · Hospital & Medical Service Plans · Nov 4, 2026
  • ← Insider ofevidence
    Oldakowski Joseph FrankVP OF FINANCE AND CONTROLLER · Sep 14, 2026
  • ← Insider ofevidence
    Thornton Joseph ClayInterim CFO · Apr 16, 2026
19
SK
Soares KarenChief Legal Officer
CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
Open-market sale · 10b5-1 plan
SELL
$90K
19.3K sh
Oct 20, 2026
Oct 20, 2026
traded Oct 20, 2026
+0d
SEC FORM 4

Evidence

19
WC
Wai ConradCEO, Counterpart Health
CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
Open-market sale · 10b5-1 plan
SELL$111K
23.6K sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC FORM 4

Evidence

16
RL
Reynoso Jamie L.CEO, Medicare Advantage
CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
Open-market sale · 10b5-1 plan
SELL$86K
18.3K sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC FORM 4

Evidence

20
TC
Thornton Joseph ClayInterim CFO
CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
Open-market sale · 10b5-1 plan
SELL$21K
4,591 sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC FORM 4

Evidence

19
SK
Soares KarenChief Legal Officer
CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
Open-market sale · 10b5-1 plan
SELL$69K
14.7K sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC FORM 4

Evidence

22
TA
Toy AndrewDirector, Chief Executive Officer
CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
Open-market sale · 10b5-1 plan
SELL$291K
62.2K sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC FORM 4

Evidence

13
RL
Reynoso Jamie L.CEO, Medicare Advantage
CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
Open-market sale · 10b5-1 plan
SELL$9,288
2,006 sh
Oct 7, 2026Oct 7, 2026
traded Oct 7, 2026
+0dSEC FORM 4

Evidence

13
RL
Reynoso Jamie L.CEO, Medicare Advantage
CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
Open-market sale · 10b5-1 plan
SELL$8,760
1,921 sh
Sep 17, 2026Sep 18, 2026
traded Sep 17, 2026
+1dSEC FORM 4

Evidence

33
WC
Wai ConradCEO, Counterpart Health
CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
Open-market sale · 10b5-1 plan
SELL$1.42M
300.0K sh
Sep 15, 2026Sep 16, 2026
traded Sep 15, 2026
+1dSEC FORM 4

Evidence

20
SK
Soares KarenChief Legal Officer
CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
Open-market sale · 10b5-1 plan
SELL$33K
6,846 sh
Sep 15, 2026Sep 15, 2026
traded Sep 15, 2026
+0dSEC FORM 4

Evidence

13
RL
Reynoso Jamie L.CEO, Medicare Advantage
CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
Open-market sale · 10b5-1 plan
SELL$44K
9,273 sh
Sep 15, 2026Sep 15, 2026
traded Sep 15, 2026
+0dSEC FORM 4

Evidence

43
OF
Oldakowski Joseph FrankVP OF FINANCE AND CONTROLLER
CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
Open-market sale
SELL$103K
20.0K sh
Sep 14, 2026Sep 14, 2026
traded Sep 14, 2026
+0dSEC FORM 4

Evidence

9
TC
Thornton Joseph ClayInterim CFO
CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
Grant or award
A—
54.3K sh
Aug 12, 2026Aug 13, 2026
traded Aug 12, 2026
+1dSEC FORM 4

Evidence

13
SK
Soares KarenChief Legal Officer
CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
Grant or award
A—
108.7K sh
Aug 12, 2026Aug 13, 2026
traded Aug 12, 2026
+1dSEC FORM 4

Evidence

11
TA
Toy AndrewDirector, Chief Executive Officer
CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
Open-market sale · 10b5-1 plan
SELL$408K
87.8K sh
Aug 10, 2026Aug 10, 2026
traded Aug 10, 2026
+0dSEC FORM 4

Evidence

1
RL
Reynoso Jamie L.CEO, Medicare Advantage
CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
Open-market sale · 10b5-1 plan
SELL$11K
2,360 sh
Jun 17, 2026Jun 18, 2026
traded Jun 17, 2026
+1dSEC FORM 4

Evidence

6
RL
Reynoso Jamie L.CEO, Medicare Advantage
CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
Open-market sale · 10b5-1 plan
SELL$36K
7,289 sh
Jun 11, 2026Jun 11, 2026
traded Jun 11, 2026
+0dSEC FORM 4

Evidence

20
WC
Wai ConradCEO, Counterpart Health
CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
Open-market sale · 10b5-1 plan
SELL$879K
220.4K sh
May 28, 2026May 28, 2026
traded May 28, 2026
+0dSEC FORM 4

Evidence

23
PP
Priest Brady PatrickCEO of Clover Care Services
CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
Open-market sale
SELL$345K
98.0K sh
May 13, 2026May 13, 2026
traded May 13, 2026
+0dSEC FORM 4

Evidence

8
PP
Priest Brady PatrickCEO of Clover Care Services
CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
Tax withholding
F$79K
36.1K sh
Apr 18, 2026Apr 21, 2026
traded Apr 18, 2026
+3dSEC FORM 4

Evidence

9
TC
Thornton Joseph ClayInterim CFO
CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
Tax withholding
F$8,482
4,158 sh
Apr 15, 2026Apr 16, 2026
traded Apr 15, 2026
+1dSEC FORM 4

Evidence

9
SK
Soares KarenChief Legal Officer
CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
Tax withholding
F$21K
10.2K sh
Apr 15, 2026Apr 16, 2026
traded Apr 15, 2026
+1dSEC FORM 4

Evidence

9
WC
Wai ConradCEO, Counterpart Health
CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
Tax withholding
F$48K
23.5K sh
Apr 15, 2026Apr 16, 2026
traded Apr 15, 2026
+1dSEC FORM 4

Evidence

5
PP
Priest Brady PatrickCEO of Clover Care Services
CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
Tax withholding
F$32K
15.5K sh
Apr 15, 2026Apr 16, 2026
traded Apr 15, 2026
+1dSEC FORM 4

Evidence

5
RL
Reynoso Jamie L.CEO, Medicare Advantage
CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
Tax withholding
F$26K
12.7K sh
Apr 15, 2026Apr 16, 2026
traded Apr 15, 2026
+1dSEC FORM 4

Evidence

12
TA
Toy AndrewDirector, Chief Executive Officer
CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
Tax withholding
F$124K
60.8K sh
Apr 15, 2026Apr 16, 2026
traded Apr 15, 2026
+1dSEC FORM 4

Evidence

5
RL
Reynoso Jamie L.CEO, Medicare Advantage
CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
Tax withholding
F$11K
6,197 sh
Apr 3, 2026Apr 7, 2026
traded Apr 3, 2026
+4dSEC FORM 4

Evidence

17
SK
Soares KarenChief Legal Officer
CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
Grant or award
A—
382.5K sh
Apr 1, 2026Apr 3, 2026
traded Apr 1, 2026
+2dSEC FORM 4

Evidence

31
PP
Priest Brady PatrickCEO of Home Care
CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
Open-market sale
SELL$380K
175.0K sh
Mar 4, 2026Mar 5, 2026
traded Mar 4, 2026
+1dSEC FORM 4

Evidence

12
PP
Priest Brady PatrickCEO of Home Care
CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
Tax withholding
F$94K
36.9K sh
Jan 18, 2026Jan 20, 2026
traded Jan 18, 2026
+2dSEC FORM 4

Evidence

18
PP
Priest Brady PatrickCEO of Home Care
CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
Tax withholding
F$51K
18.1K sh
Jan 15, 2026Jan 20, 2026
traded Jan 15, 2026
+5dSEC FORM 4

Evidence

1
RL
Reynoso Jamie L.CEO, Medicare Advantage
CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
Open-market sale · 10b5-1 plan
SELL$12K
4,597 sh
Jan 20, 2026Jan 20, 2026
traded Jan 20, 2026
+0dSEC FORM 4

Evidence

18
WC
Wai ConradCEO, Counterpart Health
CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
Tax withholding
F$73K
25.9K sh
Jan 15, 2026Jan 20, 2026
traded Jan 15, 2026
+5dSEC FORM 4

Evidence

1
RL
Reynoso Jamie L.CEO, Medicare Advantage
CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
Tax withholding · 10b5-1 plan
F$41K
14.7K sh
Jan 15, 2026Jan 20, 2026
traded Jan 15, 2026
+5dSEC FORM 4

Evidence

15
SK
Soares KarenGeneral Counsel & Secretary
CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
Tax withholding
F$33K
11.7K sh
Jan 15, 2026Jan 20, 2026
traded Jan 15, 2026
+5dSEC FORM 4

Evidence

18
TA
Toy AndrewDirector, Chief Executive Officer
CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
Tax withholding
F$171K
60.8K sh
Jan 15, 2026Jan 20, 2026
traded Jan 15, 2026
+5dSEC FORM 4

Evidence

9
GV
Garipalli VivekDirector, 10% Owner
CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
Option exercise
M—
3.34M sh
Jan 7, 2026Jan 9, 2026
traded Jan 7, 2026
+2dSEC FORM 4

Evidence

21
GV
Garipalli VivekDirector, 10% Owner
CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
Option exercise
M—
1.66M sh
Jan 7, 2026Jan 9, 2026
traded Jan 7, 2026
+2dSEC FORM 4

Evidence

30
GV
Garipalli VivekDirector, 10% Owner
CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
Tax withholding
F$4.29M
1.66M sh
Jan 7, 2026Jan 9, 2026
traded Jan 7, 2026
+2dSEC FORM 4

Evidence

17
GV
Garipalli VivekDirector, 10% Owner
CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
Option exercise
M—
1.66M sh
Jan 7, 2026Jan 9, 2026
traded Jan 7, 2026
+2dSEC FORM 4

Evidence

17
GV
Garipalli VivekDirector, 10% Owner
CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
Option exercise
M—
3.34M sh
Jan 7, 2026Jan 9, 2026
traded Jan 7, 2026
+2dSEC FORM 4

Evidence

13
RG
Robinson William G JrDirector
CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
Grant or award
A—
79.4K sh
Jan 6, 2026Jan 8, 2026
traded Jan 6, 2026
+2dSEC FORM 4

Evidence

13
LU
Loengard Anna UDirector
CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
Grant or award
A—
79.4K sh
Jan 6, 2026Jan 8, 2026
traded Jan 6, 2026
+2dSEC FORM 4

Evidence

17
EA
Edwards Carladenise ArmbristerDirector
CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
Grant or award
A—
79.4K sh
Jan 6, 2026Jan 8, 2026
traded Jan 6, 2026
+2dSEC FORM 4

Evidence

13
KL
Kouzoukas Demetrios L.Director
CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
Grant or award
A—
79.4K sh
Jan 6, 2026Jan 8, 2026
traded Jan 6, 2026
+2dSEC FORM 4

Evidence

21
TL
Tran Thomas LDirector
CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
Grant or award
A—
79.4K sh
Jan 6, 2026Jan 8, 2026
traded Jan 6, 2026
+2dSEC FORM 4

Evidence

1
RL
Reynoso Jamie L.CEO, Medicare Advantage
CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
Open-market sale · 10b5-1 plan
SELL$5,318
2,102 sh
Jan 7, 2026Jan 7, 2026
traded Jan 7, 2026
+0dSEC FORM 4

Evidence

1
RL
Reynoso Jamie L.CEO, Medicare Advantage
CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
Open-market sale · 10b5-1 plan
SELL$13K
4,913 sh
Dec 18, 2025Dec 18, 2025
traded Dec 18, 2025
+0dSEC FORM 4

Evidence

5
RL
Reynoso Jamie L.CEO, Medicare Advantage
CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
Tax withholding
F$23K
8,691 sh
Dec 15, 2025Dec 16, 2025
traded Dec 15, 2025
+1dSEC FORM 4

Evidence

9
SK
Soares KarenGeneral Counsel & Secretary
CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
Tax withholding
F$17K
6,404 sh
Dec 15, 2025Dec 16, 2025
traded Dec 15, 2025
+1dSEC FORM 4

Evidence

19
WC
Wai ConradCEO, Counterpart Health
CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
Tax withholding
F$266K
98.4K sh
Dec 14, 2025Dec 16, 2025
traded Dec 14, 2025
+2dSEC FORM 4

Evidence

5
RL
Reynoso Jamie L.CEO, Medicare Advantage
CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
Tax withholding
F$34K
12.6K sh
Dec 14, 2025Dec 16, 2025
traded Dec 14, 2025
+2dSEC FORM 4

Evidence

9
SK
Soares KarenGeneral Counsel & Secretary
CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
Tax withholding
F$18K
7,459 sh
Nov 14, 2025Nov 18, 2025
traded Nov 14, 2025
+4dSEC FORM 4

Evidence

18
TA
Toy AndrewDirector, Chief Executive Officer
CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
Tax withholding
F$228K
85.5K sh
Nov 8, 2025Nov 12, 2025
traded Nov 8, 2025
+4dSEC FORM 4

Evidence

8
RL
Reynoso Jamie L.CEO, Medicare Advantage
CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
Open-market sale · 10b5-1 plan
SELL$109K
30.4K sh
Nov 4, 2025Nov 5, 2025
traded Nov 4, 2025
+1dSEC FORM 4

Evidence

  • ← Insider ofevidence
    Priest Brady PatrickCEO of Home Care · Jan 20, 2026
  • ← Insider ofevidence
    Garipalli VivekDirector, 10% Owner · Jan 9, 2026
  • ← Insider ofevidence
    Robinson William G JrDirector · Jan 8, 2026
  • ← Insider ofevidence
    Tran Thomas LDirector · Jan 8, 2026
  • ← Insider ofevidence
    Loengard Anna UDirector · Jan 8, 2026
  • ← Insider ofevidence
    Edwards Carladenise ArmbristerDirector · Jan 8, 2026
  • ← Insider ofevidence
    Kouzoukas Demetrios L.Director · Jan 8, 2026
  • ← Insider ofevidence
    Wai ConradCEO, Counterpart Health · Dec 16, 2025
  • ← Insider ofevidence
    Soares KarenGeneral Counsel & Secretary · Nov 18, 2025
  • ← Insider ofevidence
    Toy AndrewDirector, Chief Executive Officer · Nov 12, 2025
  • ← Insider ofevidence
    Reynoso Jamie L.CEO, Medicare Advantage · Nov 5, 2025
    • Data sources
    SEC FORM 46m ago
    HOUSE PTR6m ago
    SEC 13F6m ago
    ROBINHOOD CHAIN5m ago